Tech Billionaire Sean Parker Gives $250M to Fund New Cancer Research Center in SF

Tech Billionaire Sean Parker Gives $250M to Fund New Cancer Research Center in SF


Tech billionaire Sean Parker wants to cure cancer, even if it means picking up the tab. 

Perhaps most famous for trashing Big Sur in the name of his extravagant Lord of the Rings-themed wedding, Parker also made a name for himself as one of the co-founders of Napster and the first president of Facebook. Now Parker, who suffers from a severe peanut allergy, is looking to hack the bio-medical field. 

On Wednesday morning, Parker announced the new $250 million-funded Parker Institute, a research institute to develop targeted therapies to treat cancer. That's the single largest financial contribution to the field of immunotherapy ever. 

The Parker Institute, which will be based in San Francisco, will focus on three key research areas: modifying immune cells to target tumors, boosting patient response to current immunotherapy drugs, and identifying other targets to attack tumors. The Institute will include over 40 research labs and more than 300 researchers from six key cancer centers, including New York’s Memorial Sloan Kettering, Stanford Medicine, the University of California, San Francisco, and others. The institute’s primary focus will be on the emerging field of cancer immunotherapy, in which the body’s immune system is recruited to thwart the growth of cancer cells. The twist? Parker wants contributing scientists to collaborate rather than compete for the cure. 

“Any breakthrough made at one center is immediately available to another center without any kind of IP (intellectual property) entanglements or bureaucracy,” noted Parker in an interview with Reuters.

A revenue sharing model will also be put in place to maintain incentive, and as a way to fund future research.

Even though $250 million is a drop in the bucket compared to the costs of drug development (which is typically in the billions), The Parker Institute is hoping that its partners, the pharmaceutical companies, will fund the early clinical trials and shoulder the costs of bringing a new therapy to market. 

Parker's enormous cash infusion comes three months after President Obama called for a $1 billion federal cancer research program. Billionaire shipping magnate Daniel Ludwig donated $540 million to six cancer centers in 2014 and Nike co-founder Phil Knight pledged $500 million to cancer researchers at Oregon Health & Science University in 2013. Last month, former New York City mayor Michael Bloomberg, Jones Apparel Group founder Sidney Kimmel and other philanthropists announced a $125 million donation for cancer immunotherapy research for the Johns Hopkins University medical school.

Related Articles
Now Playing at SF Symphony
View this profile on Instagram

7x7 (@7x7bayarea) • Instagram photos and videos

From Our Partners